Fortress Biotech
FBIO
#10157
Rank
โ‚น6.12 B
Marketcap
โ‚น183.78
Share price
0.52%
Change (1 day)
-15.16%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): โ‚น13.61 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are โ‚น68.46 Million. In 2025 the company made an earning of -โ‚น3.2 Billion, an increase over its 2024 earnings that were of -โ‚น11.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น13.61 B-526.53%
2025 -โ‚น3.2 Billion-72.02%
2024 -โ‚น11.42 Billion-21.6%
2023 -โ‚น14.56 Billion-28.03%
2022 -โ‚น20.23 Billion29.88%
2021 -โ‚น15.57 Billion59.8%
2020 -โ‚น9.75 Billion1.17%
2019 -โ‚น9.64 Billion-19.84%
2018 -โ‚น12.02 Billion28.99%
2017 -โ‚น9.32 Billion37.92%
2016 -โ‚น6.76 Billion32.31%
2015 -โ‚น5.11 Billion164.31%
2014 -โ‚น1.94 Billion-45.14%
2013 -โ‚น3.52 Billion37.55%
2012 -โ‚น2.56 Billion-22.91%
2011 -โ‚น3.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
โ‚น10.99 B-20.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.15 Billion-180.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-โ‚น3.23 Billion-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-โ‚น3.22 Billion-123.23%๐Ÿ‡บ๐Ÿ‡ธ USA